BioDelivery Sciences International, Inc.
BDSI
BDSI was delisted on the 22nd of March, 2022.
119 hedge funds and large institutions have $256M invested in BioDelivery Sciences International, Inc. in 2019 Q3 according to their latest regulatory filings, with 24 funds opening new positions, 48 increasing their positions, 27 reducing their positions, and 14 closing their positions.
381% more call options, than puts
Call options by funds: $404K | Put options by funds: $84K
78% more repeat investments, than reductions
Existing positions increased: 48 | Existing positions reduced: 27
71% more first-time investments, than exits
New positions opened: 24 | Existing positions closed: 14
8% more funds holding
Funds holding: 110 → 119 (+9)
11% less capital invested
Capital invested by funds: $287M → $256M (-$30.6M)
25% less funds holding in top 10
Funds holding in top 10: 4 → 3 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SAM
Silvercrest Asset Management
New York
|
+$5.83M |
| 2 |
Northern Trust
Chicago,
Illinois
|
+$3.87M |
| 3 |
N
Nuveen
Charlotte,
North Carolina
|
+$3.51M |
| 4 |
Morgan Stanley
New York
|
+$3.27M |
| 5 |
Adage Capital Partners
Boston,
Massachusetts
|
+$2.14M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
-$7.13M |
| 2 |
AOWM
Alpha Omega Wealth Management
Richmond,
Virginia
|
-$3.97M |
| 3 |
EI
EAM Investors
Solana Beach,
California
|
-$3.09M |
| 4 |
Two Sigma Investments
New York
|
-$2.86M |
| 5 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
-$2.42M |
BDSI Hedge Fund Activity: Q3 2019 in Review
119 of the 4,560 institutional investors tracked by Wall St. Rank reported a position in BioDelivery Sciences International, Inc. (BDSI) for Q3 2019, worth a combined $256M — down 11% from $287M a quarter earlier.
Buyers outnumbered sellers: 24 funds opened new BDSI positions and 14 closed out — a net gain of 10 holders — while 48 added to existing stakes and 27 trimmed.
The largest buyer was Silvercrest Asset Management, opening a new position worth an estimated $5.83M. The largest seller was Assenagon Asset Management, exiting entirely with an estimated $7.13M sold.
- 119 institutional investors held BioDelivery Sciences International, Inc. (BDSI) as of Q3 2019, up from 110 in Q2 2019.
- Funds reported $256M of BioDelivery Sciences International, Inc. stock for Q3 2019, down 11% quarter-over-quarter.
- 24 funds opened new BioDelivery Sciences International, Inc. positions in Q3 2019 and 14 closed out, a net change of +10 holders.
- The largest BioDelivery Sciences International, Inc. buyer in Q3 2019 was Silvercrest Asset Management, an estimated $5.83M added.
- The largest BioDelivery Sciences International, Inc. seller in Q3 2019 was Assenagon Asset Management, an estimated $7.13M sold.
Based on aggregated 13F filings for Q3 2019.